His lab studies the role of obesity-associated molecule leptin in controlling host neutrophil responses to Clostridium difficile infections. The lab uses samples (and clinical data) from patients with C. difficile and different murine models of C. difficile colitis to understand the role of lepin in disease pathogenesis and resolution.